<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SPH</journal-id>
<journal-id journal-id-type="hwp">spsph</journal-id>
<journal-title>Sports Health: A Multidisciplinary Approach</journal-title>
<issn pub-type="ppub">1941-7381</issn>
<issn pub-type="epub">1941-0921</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1941738112459706</article-id>
<article-id pub-id-type="publisher-id">10.1177_1941738112459706</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Primary Care</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1</subject>
<subject>41</subject>
<subject>115</subject>
<subject>157</subject>
<subject>158</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glenohumeral Joint Injections</article-title>
<subtitle>A Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gross</surname><given-names>Christopher</given-names></name>
<degrees>MD</degrees>
<xref ref-type="corresp" rid="corresp1-1941738112459706">*</xref>
<xref ref-type="aff" rid="aff1-1941738112459706">†</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dhawan</surname><given-names>Aman</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1941738112459706">†</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Harwood</surname><given-names>Daniel</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1941738112459706">†</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gochanour</surname><given-names>Eric</given-names></name>
<degrees>MA</degrees>
<xref ref-type="aff" rid="aff1-1941738112459706">†</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Romeo</surname><given-names>Anthony</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1941738112459706">†</xref>
</contrib>
</contrib-group>
<aff id="aff1-1941738112459706"><label>†</label>Rush University Medical Center, Chicago, Illinois</aff>
<author-notes>
<corresp id="corresp1-1941738112459706"><label>*</label>Christopher Gross, Rush University Medical Center, 1611 West Harrison, Suite 300, Chicago, IL 60612 (e-mail: <email>cgross144@gmail.com</email>)</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>5</volume>
<issue>2</issue>
<fpage>153</fpage>
<lpage>159</lpage>
<permissions>
<copyright-statement>© 2012 The Author(s)</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American Orthopaedic Society for Sports Medicine</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1941738112459706">
<title>Context:</title>
<p>Intra-articular injections into the glenohumeral joint are commonly performed by musculoskeletal providers, including orthopaedic surgeons, family medicine physicians, rheumatologists, and physician assistants. Despite their frequent use, there is little guidance for injectable treatments to the glenohumeral joint for conditions such as osteoarthritis, adhesive capsulitis, and rheumatoid arthritis.</p>
</sec>
<sec id="section2-1941738112459706">
<title>Evidence Acquisition:</title>
<p>We performed a comprehensive review of the available literature on glenohumeral injections to help clarify the current evidence-based practice and identify deficits in our understanding. We searched MEDLINE (1948 to December 2011 [week 1]) and EMBASE (1980 to 2011 [week 49]) using various permutations of <italic>intra-articular injections</italic> AND (<italic>corticosteroid</italic> OR <italic>hyaluronic acid</italic>) and (<italic>adhesive capsulitis</italic> OR <italic>arthritis</italic>).</p>
</sec>
<sec id="section3-1941738112459706">
<title>Results:</title>
<p>We identified 1 and 7 studies that investigated intra-articular corticosteroid injections for the treatment of osteoarthritis and adhesive capsulitis, respectively. Two and 3 studies investigated the use of hyaluronic acid in osteoarthritis and adhesive capsulitis, respectively. One study compared corticosteroids and hyaluronic acid injections in the treatment of osteoarthritis, and another discussed adhesive capsulitis.</p>
</sec>
<sec id="section4-1941738112459706">
<title>Conclusion:</title>
<p>Based on existing studies and their level of evidence, there is only expert opinion to guide corticosteroid injection for osteoarthritis as well as hyaluronic acid injection for osteoarthritis and adhesive capsulitis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>glenohumeral</kwd>
<kwd>arthritis</kwd>
<kwd>injection</kwd>
<kwd>corticosteroid</kwd>
<kwd>hyaluronic acid</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March/April 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Shoulder disorders are a cause for significant morbidity, with a prevalence of 6.9% to 34% in the general population and up to 21% in those over 70 years old.<sup><xref ref-type="bibr" rid="bibr15-1941738112459706">15</xref></sup> These debilitating disorders present a challenge to the treating clinician; conservative treatment options are finite before surgery is indicated. Current modalities include physical therapy, corticosteroid injection, viscosupplementation with hyaluronic acid (HA), nonsteroidal anti-inflammatory drugs (NSAIDs), and glucosamine and chondroitin sulfate. The success of these therapies may in part be based on the self-limiting nature of conditions such as adhesive capsulitis.</p>
<p>Shoulder injections of corticosteroids and HA are not limited to the glenohumeral joint. Rather, they are used in conditions of the subacromial space, acromioclavicular joint, bicipital tendon sheath, sternoclavicular joint, and the subcoracoid bursa.<sup><xref ref-type="bibr" rid="bibr51-1941738112459706">51</xref></sup> Though the use of HA is approved by the Food and Drug Administration for intra-articular injections in the knee, it remains an off-label use in the shoulder and its surrounding spaces. In this review, intra-articular injections to the pathologies affecting the glenohumeral joint are addressed with focus on corticosteroids and viscosupplementation.</p>
<p>The accuracy of injection delivery to the glenohumeral joint proper has been unreliable.<sup><xref ref-type="bibr" rid="bibr55-1941738112459706">55</xref></sup> Tobola et al<sup><xref ref-type="bibr" rid="bibr55-1941738112459706">55</xref></sup> examined the accuracy of intra-articular injection utilizing anterior, supraclavicular, and posterior approaches. Differences among these approaches were not significant; the anterior approach had a reliability of 64.7%, compared with 45.7% and 45.5% for supraclavicular and posterior approaches, respectively. However, anatomic delivery of injectable medications into the glenohumeral joint may not be relevant.<sup><xref ref-type="bibr" rid="bibr26-1941738112459706">26</xref></sup> Hegedus et al found that relief of shoulder pain with injectables did not correlate with clinician experience, injection intra- or extracapsularly, and duration of symptoms.<sup><xref ref-type="bibr" rid="bibr26-1941738112459706">26</xref></sup></p>
<sec id="section5-1941738112459706">
<title>Corticosteroids</title>
<p>Injectable steroids have been in use for decades to treat various disorders of the glenohumeral joint.<sup><xref ref-type="bibr" rid="bibr3-1941738112459706">3</xref></sup> Much of the evidence supporting the use of corticosteroids is anecdotal. Indeed, level 1 and 2 evidence supporting the use of intra-articular corticosteroids is lacking. Confounding variables such as physiotherapy, analgesics, and NSAIDs also make it difficult to arrive at definitive conclusions or recommendations.<sup><xref ref-type="bibr" rid="bibr3-1941738112459706">3</xref></sup></p>
<sec id="section6-1941738112459706">
<title>Properties</title>
<p>The pharmacologic properties of corticosteroids have been well documented.<sup><xref ref-type="bibr" rid="bibr10-1941738112459706">10</xref>,<xref ref-type="bibr" rid="bibr23-1941738112459706">23</xref></sup> They act locally and are much like the anti-inflammatory effects of systemic steroids<sup><xref ref-type="bibr" rid="bibr10-1941738112459706">10</xref>,<xref ref-type="bibr" rid="bibr23-1941738112459706">23</xref></sup> In the knee, local lymphocytes, macrophages, mast cells, and overall edema of the joint after injection with Depo-Medrol occurs.<sup><xref ref-type="bibr" rid="bibr45-1941738112459706">45</xref></sup> Local corticosteroid injection also decreases the erythrocyte-sedimentation rate and C-reactive protein in patients with rheumatoid arthritis.<sup><xref ref-type="bibr" rid="bibr16-1941738112459706">16</xref></sup></p>
<p>The injectable formulations vary by molecular size, crystal structure, serum half-life, solubility, fluorination, and duration of action.<sup><xref ref-type="bibr" rid="bibr16-1941738112459706">16</xref></sup> Water-soluble steroids (dexamethasone) rapidly dissipate from the joint and exert many systemic side effects.<sup><xref ref-type="bibr" rid="bibr16-1941738112459706">16</xref></sup> These are primarily helpful with extra-articular uses such as carpal tunnel. Conversely, formulations with lower solubility maintain longer synovial levels with decreased systemic effects.<sup><xref ref-type="bibr" rid="bibr16-1941738112459706">16</xref></sup> The length of action for each steroid varies widely among different corticosteroids (<xref ref-type="table" rid="table1-1941738112459706">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr5-1941738112459706">5</xref>,<xref ref-type="bibr" rid="bibr10-1941738112459706">10</xref>,<xref ref-type="bibr" rid="bibr23-1941738112459706">23</xref></sup> While decreased solubility maintains longevity within the synovium, solubility is not correlated to duration of action.<sup><xref ref-type="bibr" rid="bibr46-1941738112459706">46</xref></sup> The chemical structure of the steroid also affects activity: fluorinated compounds (Decadron, Kenalog, Aristospan, Celestone) have increased activity and systemic absorption<sup><xref ref-type="bibr" rid="bibr42-1941738112459706">42</xref></sup> and a higher rate of side effects. Moore suggests that the use of fluorinated compounds be limited to intra-articular injections because of the higher rate of tendon rupture and subcutaneous collagen atrophy.<sup><xref ref-type="bibr" rid="bibr39-1941738112459706">39</xref></sup> Flocculation (colloids out of solution) can also occur with the mixture of corticosteroids and local anesthetic agents and may inhibit the local effects of the steroid.</p>
<table-wrap id="table1-1941738112459706" position="float">
<label>Table 1.</label>
<caption><p>Injectable corticosteroid properties.</p></caption>
<graphic alternate-form-of="table1-1941738112459706" xlink:href="10.1177_1941738112459706-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Generic Name: Trade Name</th>
<th align="center">Dose, mg<sup><xref ref-type="bibr" rid="bibr17-1941738112459706">17</xref></sup></th>
<th align="center">Solubility, % wt/vol<sup><xref ref-type="bibr" rid="bibr20-1941738112459706">20</xref></sup></th>
<th align="center">Mean Duration of Action, d<sup><xref ref-type="bibr" rid="bibr5-1941738112459706">5</xref>,<xref ref-type="bibr" rid="bibr23-1941738112459706">23</xref></sup></th>
<th align="center">Fluorinated</th>
</tr>
</thead>
<tbody>
<tr>
<td>Methylprednisolone diacetate: Depo-Medrol</td>
<td>40-60</td>
<td>.001</td>
<td>7-84</td>
<td>No</td>
</tr>
<tr>
<td>Prednisolone tebutate: Hydeltra-TBA</td>
<td>5-50</td>
<td>.001</td>
<td>10-15</td>
<td>No</td>
</tr>
<tr>
<td>Triamcinolone acetonide: Kenalog</td>
<td>5-40</td>
<td>.004</td>
<td>11</td>
<td>Yes</td>
</tr>
<tr>
<td>Triamcinolone hexetidine: Aristospan</td>
<td>5-40</td>
<td>.0002</td>
<td>3</td>
<td>Yes</td>
</tr>
<tr>
<td>Betamethasone sodium phosphate, betamethasone acetate: Celestone Soluspan</td>
<td>1.5-6</td>
<td>NA</td>
<td>9</td>
<td>Yes</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The most effective dosage and specific type of corticosteroid are not known (<xref ref-type="table" rid="table1-1941738112459706">Table 1</xref>). Recommendations for the frequency of intra-articular injection are empirically based on the recommendations of the American College of Rheumatology.<sup><xref ref-type="bibr" rid="bibr25-1941738112459706">25</xref></sup> Generally, a steroid should not be injected into the same joint more than every 3 months.<sup><xref ref-type="bibr" rid="bibr25-1941738112459706">25</xref></sup> Aspirating synovial fluid at the time of injection and resting the joint may decrease painful relapses.<sup><xref ref-type="bibr" rid="bibr13-1941738112459706">13</xref>,<xref ref-type="bibr" rid="bibr19-1941738112459706">19</xref></sup></p>
</sec>
<sec id="section7-1941738112459706">
<title>Side Effects and Complications</title>
<p>The complication rate of intra-articular corticosteroid injections is relatively low (1%-15%).<sup><xref ref-type="bibr" rid="bibr25-1941738112459706">25</xref></sup> One of the most common complications is transient pain during injection and/or postinjection (6.7%). Flare-up pain usually lasts 24 to 48 hours and most likely results from a transient reactive synovitis in response to the steroid crystals. Facial flushing may occur in up to 15% of patients, with a greater number of women affected. The effects are transient, lingering for no more than 3 days.<sup><xref ref-type="bibr" rid="bibr33-1941738112459706">33</xref></sup> Skin or subcutaneous fat atrophy may occur after corticosteroid injection and may persist longer than 6 months (.35%).<sup><xref ref-type="bibr" rid="bibr32-1941738112459706">32</xref></sup> Septic arthritis is the greatest concern, occurring from 1:3000 to 1:50 000.<sup><xref ref-type="bibr" rid="bibr14-1941738112459706">14</xref></sup> Hyaline cartilage damage has been reported in animal models but not in humans.<sup><xref ref-type="bibr" rid="bibr16-1941738112459706">16</xref></sup> Contraindications to intra-articular corticosteroid injection include a prosthetic joint, septic arthritis, and joint fracture.<sup><xref ref-type="bibr" rid="bibr32-1941738112459706">32</xref></sup></p>
<p>The hypothalamic pituitary-adrenal axis may be suppressed with corticosteroids injected locally. A single intra-articular injection of methylprednisone acetate showed an average 21.5% reduction in serum cortisol 24 hours after injection normalizing in 3 days.<sup><xref ref-type="bibr" rid="bibr34-1941738112459706">34</xref></sup></p>
</sec>
<sec id="section8-1941738112459706">
<title>Glenohumeral Arthritis</title>
<p>The glenohumeral joint is the third-most-common large joint affected by degenerative joint disease.<sup><xref ref-type="bibr" rid="bibr37-1941738112459706">37</xref></sup> It is usually diagnosed at much later stages of disease and less frequently than knees or hips. Conservative management for glenohumeral arthritis includes activity modification, physical therapy to promote strength and flexibility, nonnarcotic medications to reduce pain, intra-articular corticosteroid injections to reduce local inflammation, viscosupplementation, and general health maintenance.<sup><xref ref-type="bibr" rid="bibr44-1941738112459706">44</xref></sup></p>
<p>There is currently no level 1 or 2 studies on intra-articular corticosteroid injections as a treatment modality for glenohumeral arthritis.<sup><xref ref-type="bibr" rid="bibr29-1941738112459706">29</xref></sup> While literature suggests that injectable corticosteroid therapy is a treatment modality for shoulder arthritis, not one lists shoulder-specific evidence. According to the most recent guidelines<sup><xref ref-type="bibr" rid="bibr54-1941738112459706">54</xref></sup> for the treatment of glenohumeral arthritis, by the American Academy of Orthopaedic Surgeons, the use of injectable corticosteroids is inconclusive. Unfortunately, the organization is unable to recommend for or against glenohumeral corticosteroid injections.<sup><xref ref-type="bibr" rid="bibr54-1941738112459706">54</xref></sup> One study does address corticosteroids in comparison to HA in treating shoulder osteoarthritis.<sup><xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref></sup> This is discussed in the HA section (<xref ref-type="table" rid="table2-1941738112459706">Table 2</xref>).</p>
<table-wrap id="table2-1941738112459706" position="float">
<label>Table 2.</label>
<caption><p>Study characteristics of hyaluronic acid and corticosteroid use for arthritis.</p></caption>
<graphic alternate-form-of="table2-1941738112459706" xlink:href="10.1177_1941738112459706-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Type</th>
<th align="center">Patients, n</th>
<th align="center">Follow-up, wk</th>
<th align="center">Treatment Arm</th>
<th align="center">Control Arm</th>
<th align="center">Outcomes Measures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Merolla<sup><xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref></sup></td>
<td>Retrospective controlled</td>
<td>84</td>
<td>26</td>
<td>Hylan G-F 20</td>
<td>Methylprednisolone acetate</td>
<td>Constant-Murley, Shoulder Pain and Disability Index, satisfaction</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The use of corticosteroids in glenohumeral arthritis is based on its effects on the synovium and surrounding tissue, as well as its clinical efficacy in other arthrodial joints, especially the knee.<sup><xref ref-type="bibr" rid="bibr6-1941738112459706">6</xref></sup> Triamcinolone hexetidine injection in knee osteoarthritis<sup><xref ref-type="bibr" rid="bibr19-1941738112459706">19</xref></sup> showed improved visual analog pain scale at 1 week compared to placebo. An intra-articular injection of methylprednisolone acetate demonstrated a significant reduction in pain at 3 weeks.<sup><xref ref-type="bibr" rid="bibr30-1941738112459706">30</xref></sup> However, at 6 to 8 weeks, no appreciable difference was seen in either steroid. A more successful response was seen in patients with an intra-articular effusion and aspiration of synovial fluid at the time of injection.<sup><xref ref-type="bibr" rid="bibr30-1941738112459706">30</xref></sup> A 24-month randomized trial with triamcinolone acetate injection of symptomatic knees every 3 months noted improvement in range of motion and slightly improved pain at 1 year.<sup><xref ref-type="bibr" rid="bibr47-1941738112459706">47</xref></sup> Patients in the steroid group had improved knee pain and stiffness and no difference in joint space at the end of 2 years.</p>
</sec>
<sec id="section9-1941738112459706">
<title>Adhesive Capsulitis</title>
<p>Adhesive capsulitis (frozen shoulder) affects 2% to 5% of the adult population.<sup><xref ref-type="bibr" rid="bibr41-1941738112459706">41</xref></sup> It may be idiopathic or present after shoulder immobilization, trauma, or surgery.<sup><xref ref-type="bibr" rid="bibr56-1941738112459706">56</xref></sup> It may be intrinsic (tightening of the joint capsule) or extrinsic (scarring of the rotator interval or external rotators). It is usually self-limiting and has 3 phases: freezing, frozen, and thawing.<sup><xref ref-type="bibr" rid="bibr56-1941738112459706">56</xref></sup> In the first stage, capsular inflammation occurs<sup><xref ref-type="bibr" rid="bibr8-1941738112459706">8</xref></sup>; consequently, intra-articular corticosteroid injections are thought to be best during this initial phase. In a systematic review of corticosteroid injections compared with physical therapy in the treatment of adhesive capsulitis, greater improvements in shoulder pain and function in the short term are reported with glenohumeral joint corticosteroid injections versus physical therapy (<xref ref-type="table" rid="table3-1941738112459706">Table 3</xref>).<sup><xref ref-type="bibr" rid="bibr8-1941738112459706">8</xref></sup> Greater efficacy of glenohumeral corticosteroid injections compared with physical therapy<sup><xref ref-type="bibr" rid="bibr57-1941738112459706">57</xref></sup> persisted at 1 year and were more beneficial than physical therapy and NSAIDs combined.<sup><xref ref-type="bibr" rid="bibr4-1941738112459706">4</xref></sup></p>
<table-wrap id="table3-1941738112459706" position="float">
<label>Table 3.</label>
<caption><p>Study characteristics of corticosteroid treatment of adhesive capsulitis.<sup><xref ref-type="table-fn" rid="table-fn1-1941738112459706"><italic>a</italic></xref></sup></p></caption>
<graphic alternate-form-of="table3-1941738112459706" xlink:href="10.1177_1941738112459706-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Type</th>
<th align="center">Patients, n</th>
<th align="center">Follow-up, wk</th>
<th align="center">Treatment Arm</th>
<th align="center">Control Arm</th>
<th align="center">Outcomes Measures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arlsan<sup><xref ref-type="bibr" rid="bibr4-1941738112459706">4</xref></sup></td>
<td>RCT</td>
<td>20</td>
<td>2, 12</td>
<td>40 mg, methylprednisolone</td>
<td>NSAIDs, PT</td>
<td>VAS, ROM</td>
</tr>
<tr>
<td>Blanchard<sup><xref ref-type="bibr" rid="bibr8-1941738112459706">8</xref></sup></td>
<td>SR</td>
<td>362</td>
<td>Up to 52</td>
<td>Triamcinolone or methylprednisolone</td>
<td>PT</td>
<td>VAS, ROM, SPADI, SF-36</td>
</tr>
<tr>
<td>de Jong<sup><xref ref-type="bibr" rid="bibr18-1941738112459706">18</xref></sup></td>
<td>RCT</td>
<td>25</td>
<td>1,3,6</td>
<td>40 mg, triamcinolone</td>
<td>10 mg, triamcinolone</td>
<td>Pain, sleep disturbance</td>
</tr>
<tr>
<td>Griesser<sup><xref ref-type="bibr" rid="bibr24-1941738112459706">24</xref></sup></td>
<td>SR</td>
<td>409</td>
<td>Up to 52</td>
<td>Triamcinolone or methylprednisolone</td>
<td>PT, oral steroid, manipulation, ice pack, no treatment</td>
<td>SPADI, VAS, SF-36, ROM</td>
</tr>
<tr>
<td>Rizk<sup><xref ref-type="bibr" rid="bibr48-1941738112459706">48</xref></sup></td>
<td>RCT</td>
<td>48</td>
<td>3</td>
<td>40 mg, methylprednisolone</td>
<td>Lidocaine, PT</td>
<td>Pain, ROM</td>
</tr>
<tr>
<td>van der Windt<sup><xref ref-type="bibr" rid="bibr57-1941738112459706">57</xref></sup></td>
<td>RCT</td>
<td>109</td>
<td>3, 7, 13, 26, 52</td>
<td>40 mg, triamcinolone (no more than 3 injections)</td>
<td>12 sessions of PT</td>
<td>VAS day and night, passive lateral rotation and abduction</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1941738112459706">
<label>a</label>
<p>RCT, randomized controlled trial; SR, systematic review; NSAIDs, nonsteroidal anti-inflammatory drugs; PT, physical therapy; VAS, visual analog scale; ROM, range of motion; SPADI, Shoulder Pain and Disability Index.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The dose of steroid affects the outcome of adhesive capsulitis. Glenohumeral injection of 40 mg triamcinolone acetonide (vs 10 mg)<sup><xref ref-type="bibr" rid="bibr18-1941738112459706">18</xref></sup> relieved more pain at 6 weeks. Arm function and glenohumeral range of motion improved, while sleep disturbances were unchanged.<sup><xref ref-type="bibr" rid="bibr61-1941738112459706">61</xref></sup></p>
<p>The data for corticosteroid treatment versus placebos or traditional oral medication are sparse. Studies comparing corticosteroid injection to lidocaine injection<sup><xref ref-type="bibr" rid="bibr48-1941738112459706">48</xref></sup> have mixed results. In a double-blind intention-to-treat analysis at 6 months, there were no differences in range of motion or pain in the corticosteroid or lidocaine injection group.<sup><xref ref-type="bibr" rid="bibr48-1941738112459706">48</xref></sup> In an unblinded study comparing steroid injection to NSAID therapy, glenohumeral injection reduced pain more than analgesia alone at 6 weeks.<sup><xref ref-type="bibr" rid="bibr35-1941738112459706">35</xref>,<xref ref-type="bibr" rid="bibr48-1941738112459706">48</xref></sup> Interestingly, the location of injection was not a determinant of clinical effect; a steroid injection into the bicipital tendon sheath also provided pain relief. A systematic review of existing level 1 and 2 evidence comparing injectable steroids and no treatment, ice pack, or low volume of intra-articular saline solution showed that the corticosteroid group provided earlier return of shoulder motion and improvement in Shoulder Pain and Disability Index scores, but at 52 weeks, there was no difference between the groups.<sup><xref ref-type="bibr" rid="bibr24-1941738112459706">24</xref></sup></p>
</sec>
</sec>
<sec id="section10-1941738112459706">
<title>Hyaluronic Acid</title>
<p>Hyaluronic acid is a high–molecular weight glycosaminoglycan composed of repeating disaccharide units of glucuronic acid and N-acetyl-glucosamine.<sup><xref ref-type="bibr" rid="bibr9-1941738112459706">9</xref>,<xref ref-type="bibr" rid="bibr52-1941738112459706">52</xref></sup> The viscoelastic properties of HA play a critical role in joint mechanics in synovial fluid.<sup><xref ref-type="bibr" rid="bibr9-1941738112459706">9</xref>,<xref ref-type="bibr" rid="bibr50-1941738112459706">50</xref>,<xref ref-type="bibr" rid="bibr52-1941738112459706">52</xref>,<xref ref-type="bibr" rid="bibr59-1941738112459706">59</xref></sup> Exogenous HA has anti-inflammatory, anabolic, analgesic, and chondroprotective effects.<sup><xref ref-type="bibr" rid="bibr28-1941738112459706">28</xref>,<xref ref-type="bibr" rid="bibr40-1941738112459706">40</xref></sup></p>
<sec id="section11-1941738112459706">
<title>Properties</title>
<p>In animal models, HA preparations with high molecular weight have increased efficacy.<sup><xref ref-type="bibr" rid="bibr27-1941738112459706">27</xref></sup> Though proven to have anti-inflammatory and analgesic effects, the precise mechanism for pain relief is not known, given that it has a short half-life in the joint.<sup><xref ref-type="bibr" rid="bibr21-1941738112459706">21</xref>,<xref ref-type="bibr" rid="bibr40-1941738112459706">40</xref></sup> The temporary improvement of normal viscoelastic joint properties likely contributes to pain relief, but it is unclear if HA anti-inflammatory effects contribute to viscosupplementation long-term relief. HA may coat the articular cartilage and prevent loss of essential chondrocyte matrix molecules, such as prostaglandins.<sup><xref ref-type="bibr" rid="bibr40-1941738112459706">40</xref></sup> Exogenous HA may facilitate the de novo synthesis of HA.<sup><xref ref-type="bibr" rid="bibr2-1941738112459706">2</xref>,<xref ref-type="bibr" rid="bibr40-1941738112459706">40</xref></sup> The interplay between mechanical and biological effects likely contributes to the difficulty in assessing the therapeutic effect for viscosupplementation. While the use of viscosupplementation in joints other than the knee has not yet been approved by the Food and Drug Administration, recent clinical studies have begun to address its potential use in the hip, ankle, and, more recently, the shoulder.<sup><xref ref-type="bibr" rid="bibr50-1941738112459706">50</xref>,<xref ref-type="bibr" rid="bibr52-1941738112459706">52</xref></sup></p>
</sec>
<sec id="section12-1941738112459706">
<title>Side Effects and Complications</title>
<p>The side effect profile of viscosupplementation includes acute local reactions (pain and swelling in the joint within 72 hours), flare-up of pseudogout, and pseudosepsis (acute systemic inflammatory reactions).<sup><xref ref-type="bibr" rid="bibr22-1941738112459706">22</xref>,<xref ref-type="bibr" rid="bibr36-1941738112459706">36</xref>,<xref ref-type="bibr" rid="bibr60-1941738112459706">60</xref></sup> In a series of 4253 injections, acute local reactions occurred at a rate of 2.4%<sup><xref ref-type="bibr" rid="bibr31-1941738112459706">31</xref></sup>; another study reported adverse reactions in 1.2% per injection or 5.2% per patient in a series of 1489 injections.<sup><xref ref-type="bibr" rid="bibr58-1941738112459706">58</xref></sup> Higher molecular weight HA preparations have been shown to be safer with a decreased infection rate, since lower weight preparations require more frequent treatment to achieve the same clinical result.<sup><xref ref-type="bibr" rid="bibr1-1941738112459706">1</xref></sup> Preparations that include HA derived from rooster combs may have increased immunogenicity and may account for the few cases of pseudosepsis in patients.<sup><xref ref-type="bibr" rid="bibr60-1941738112459706">60</xref></sup></p>
<p>Several publications conflict on whether rates of adverse reactions are increased in patients with repeat injections of HA.<sup><xref ref-type="bibr" rid="bibr36-1941738112459706">36</xref>,<xref ref-type="bibr" rid="bibr58-1941738112459706">58</xref>,<xref ref-type="bibr" rid="bibr60-1941738112459706">60</xref></sup> While some studies report an eightfold increase in adverse reactions in subsequent injections, others show adverse reaction rates less than those from the first series of injections.<sup><xref ref-type="bibr" rid="bibr36-1941738112459706">36</xref>,<xref ref-type="bibr" rid="bibr60-1941738112459706">60</xref></sup> Another series reports the incidence of treatment-related adverse reactions to be 0.8% (3.4% of patients) in the first series, 4.3% (13.1%) in the second, and 5.4% (17.3%) in the third.<sup><xref ref-type="bibr" rid="bibr58-1941738112459706">58</xref></sup></p>
</sec>
<sec id="section13-1941738112459706">
<title>Glenohumeral Osteoarthritis</title>
<p>Patients with glenohumeral osteoarthritis treated with HA had a significant decrease in pain and significant improvements in activities of daily living, based on visual analog scale, University of California–Los Angeles, and Simple Shoulder Test scores (<xref ref-type="table" rid="table4-1941738112459706">Table 4</xref>).<sup><xref ref-type="bibr" rid="bibr50-1941738112459706">50</xref></sup> More patients slept comfortably after treatment (56%) than before (15%). However, the authors were unable to conclude which patients would benefit from HA therapy. Another prospective trial showed that at 3 months, the visual analog scale significantly decreased from 61.2 to 37.1 after 1 or 2 injections of HA.<sup><xref ref-type="bibr" rid="bibr43-1941738112459706">43</xref></sup></p>
<table-wrap id="table4-1941738112459706" position="float">
<label>Table 4.</label>
<caption><p>Study design for intra-articular injections of hyaluronic acid for osteoarthritis.<sup><xref ref-type="table-fn" rid="table-fn2-1941738112459706"><italic>a</italic></xref></sup></p></caption>
<graphic alternate-form-of="table4-1941738112459706" xlink:href="10.1177_1941738112459706-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Type</th>
<th align="center">Patients, n</th>
<th align="center">Follow-up, wk</th>
<th align="center">Treatment Arm</th>
<th align="center">Control Arm</th>
<th align="center">Outcomes Measures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Noel<sup><xref ref-type="bibr" rid="bibr43-1941738112459706">43</xref></sup></td>
<td>Prospective</td>
<td>39</td>
<td>26</td>
<td>Hylan G-F 20</td>
<td>None</td>
<td>VAS</td>
</tr>
<tr>
<td>Silverstein<sup><xref ref-type="bibr" rid="bibr50-1941738112459706">50</xref></sup></td>
<td>Prospective</td>
<td>30</td>
<td>26</td>
<td>3 injections of Hylan G-F 20</td>
<td>None</td>
<td>VAS, UCLA, SST</td>
</tr>
<tr>
<td>Blaine<sup><xref ref-type="bibr" rid="bibr7-1941738112459706">7</xref></sup></td>
<td>RCT</td>
<td>456</td>
<td>26</td>
<td>Sodium hyaluronate</td>
<td>Saline</td>
<td>VAS</td>
</tr>
<tr>
<td>Merolla<sup><xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref></sup></td>
<td>Retrospective controlled</td>
<td>84</td>
<td>26</td>
<td>Hylan G-F 20</td>
<td>Methylprednisolone acetate</td>
<td>Constant-Murley, SPADI, satisfaction</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1941738112459706">
<label>a</label>
<p>RCT, randomized controlled trial; VAS, visual analog scale; UCLA, University of California–Los Angeles; SST, Simple Shoulder Test; SPADI, Shoulder Pain and Disability Index.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In a multicenter, randomized, double-blind, controlled trial,<sup><xref ref-type="bibr" rid="bibr7-1941738112459706">7</xref></sup> the efficacy and safety of intra-articular injections of sodium hyaluronate (molecular weight, 500 to 730 kDa) for persistent shoulder pain and limited function, including glenohumeral joint arthritis, torn rotator cuff, and/or adhesive capsulitis, were studied. Patients with osteoarthritis showed significant pain and visual analog scale score improvement with both 3 and 5 glenohumeral injection regimens at both 7 and 26 weeks. However, this improvement was not maintained for every intermediary time point, and results are similar to previous studies investigating 3- and 5-injection regimens in the knee.<sup><xref ref-type="bibr" rid="bibr12-1941738112459706">12</xref></sup></p>
<p>One study evaluated the efficacy of HA versus methylprednisolone acetate in arthritis in 84 patients at 1-, 3-, and 6-month intervals.<sup><xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref></sup> The HA group showed a significant pain reduction, improvement in Constant-Murley and Shoulder Pain and Disability Index scores, and satisfaction at all 3 follow-up times. In the corticosteroid group, improvements in pain, functional outcomes, and satisfaction were present only at 1 month. Outcomes were relative to the degree of arthritis and the presence of rotator cuff tears.</p>
</sec>
<sec id="section14-1941738112459706">
<title>Adhesive Capsulitis</title>
<p>In a clinical study of viscosupplementation for adhesive capsulitis,<sup><xref ref-type="bibr" rid="bibr27-1941738112459706">27</xref></sup> sodium hyaluronate was injected into the glenohumeral joint of 70 patients once per week over the course of 5 weeks. A global improvement rating demonstrated that 51 of 62 patients (82.3%) were slightly improved or better and that 32 of 62 patients (51.6%) were moderately improved or better (<xref ref-type="table" rid="table5-1941738112459706">Table 5</xref>). Pain at rest, motion, pressure, activities of daily living, and range of motion improved.<sup><xref ref-type="bibr" rid="bibr27-1941738112459706">27</xref></sup></p>
<table-wrap id="table5-1941738112459706" position="float">
<label>Table 5.</label>
<caption><p>Study design of hyaluronic acid injection for adhesive capsulitis.<sup><xref ref-type="table-fn" rid="table-fn3-1941738112459706"><italic>a</italic></xref></sup></p></caption>
<graphic alternate-form-of="table5-1941738112459706" xlink:href="10.1177_1941738112459706-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Type</th>
<th align="center">Patients, n</th>
<th align="center">Follow-up, wk</th>
<th align="center">Treatment Arm</th>
<th align="center">Control Arm</th>
<th align="center">Outcomes measures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Itokazu<sup><xref ref-type="bibr" rid="bibr27-1941738112459706">27</xref></sup></td>
<td>Prospective</td>
<td>62</td>
<td>8</td>
<td>Sodium hyaluronate 25 mg (1/wk × 5)</td>
<td>None</td>
<td>ROM; pain at rest, motion, pressure</td>
</tr>
<tr>
<td>Calis<sup><xref ref-type="bibr" rid="bibr11-1941738112459706">11</xref></sup></td>
<td>RCT</td>
<td>95</td>
<td>12</td>
<td>Sodium hyaluronate</td>
<td>Triamcinolone acetate vs PT vs no treatment</td>
<td>Pain severity with passive ROM, functional considerations</td>
</tr>
<tr>
<td>Rovetta<sup><xref ref-type="bibr" rid="bibr49-1941738112459706">49</xref></sup></td>
<td>RCT</td>
<td>30</td>
<td>26</td>
<td>Sodium hyaluronate + triamcinolone</td>
<td>Triamcinolone + PT</td>
<td>ROM, pain</td>
</tr>
<tr>
<td>Tamai<sup><xref ref-type="bibr" rid="bibr53-1941738112459706">53</xref></sup></td>
<td>Prospective</td>
<td>11</td>
<td>6</td>
<td>Sodium hyaluronate</td>
<td>None</td>
<td>Coefficient of enhancement of synovium on MRI, JOA score</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1941738112459706">
<label>a</label>
<p>RCT, randomized controlled trial; ROM, range of motion; PT, physical therapy; MRI, magnetic resonance imaging; JOA, Japanese Orthopaedic Association shoulder score.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In a study of HA injection, triamcinolone acetonide, or physical therapy modalities,<sup><xref ref-type="bibr" rid="bibr11-1941738112459706">11</xref></sup> significant improvement was observed in pain, passive range of motion, and function on the 15th day after treatment and the third month for both HA treatment and steroid injections. Physical therapy alone demonstrated better pain reduction, passive range of motion, and function compared with both corticosteroid and HA injection.<sup><xref ref-type="bibr" rid="bibr11-1941738112459706">11</xref></sup> While adhesive capsulitis can be treated with physical therapy, a combined HA and corticosteroids injection may offer a suitable alternative; patients that received both injections fared better functionally than those receiving corticosteroids only.<sup><xref ref-type="bibr" rid="bibr49-1941738112459706">49</xref></sup> Researchers do not know why HA injections improve adhesive capsulitis outcomes. One study suggests that clinical improvement may be related to a decrease in synovial inflammation or decreased synovial perfusion in the glenohumeral joint<sup><xref ref-type="bibr" rid="bibr53-1941738112459706">53</xref></sup>; another hypothesizes that the HA may decrease shoulder soft tissue retraction by influencing the volume of synovial fluid or regulating joint osmotic pressure.<sup><xref ref-type="bibr" rid="bibr49-1941738112459706">49</xref></sup></p>
</sec>
</sec>
<sec id="section15-1941738112459706" sec-type="conclusions">
<title>Conclusions</title>
<p>There is little scientific support in the literature for the use of intra-articular corticosteroid injections to treat glenohumeral arthritis.<sup><xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref>,<xref ref-type="bibr" rid="bibr54-1941738112459706">54</xref></sup> The use of intra-articular corticosteroids for adhesive capsulitis has inconsistent patient-oriented evidence but better literature support than for glenohumeral arthritis.<sup><xref ref-type="bibr" rid="bibr4-1941738112459706">4</xref>,<xref ref-type="bibr" rid="bibr8-1941738112459706">8</xref>,<xref ref-type="bibr" rid="bibr18-1941738112459706">18</xref>,<xref ref-type="bibr" rid="bibr24-1941738112459706">24</xref>,<xref ref-type="bibr" rid="bibr48-1941738112459706">48</xref>,<xref ref-type="bibr" rid="bibr57-1941738112459706">57</xref></sup> Intra-articular HA injections for osteoarthritis and adhesive capsulitis show promise but lack any well-designed prospective trials to fully evaluate their effectiveness.<sup><xref ref-type="bibr" rid="bibr7-1941738112459706">7</xref>,<xref ref-type="bibr" rid="bibr11-1941738112459706">11</xref>,<xref ref-type="bibr" rid="bibr27-1941738112459706">27</xref>,<xref ref-type="bibr" rid="bibr38-1941738112459706">38</xref>,<xref ref-type="bibr" rid="bibr43-1941738112459706">43</xref>,<xref ref-type="bibr" rid="bibr49-1941738112459706">49</xref>,<xref ref-type="bibr" rid="bibr50-1941738112459706">50</xref>,<xref ref-type="bibr" rid="bibr53-1941738112459706">53</xref></sup> While the use of corticosteroids and HA in the conservative management of osteoarthritis and adhesive capsulitis is widespread, its basis rests on limited evidence.</p>
<graphic xlink:href="10.1177_1941738112459706-img1.tif"/>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1941738112459706">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adams</surname><given-names>ME</given-names></name>
<name><surname>Lussier</surname><given-names>AJ</given-names></name>
<name><surname>Peyron</surname><given-names>JG</given-names></name>
</person-group>. <article-title>A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee</article-title>. <source>Drug Safety</source>. <year>2000</year>;<volume>23</volume>:<fpage>115</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr2-1941738112459706">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Altman</surname><given-names>RD</given-names></name>
</person-group>. <article-title>Osteoarthritis: differentiation from rheumatoid arthritis, causes of pain, treatment</article-title>. <source>Postgrad Med</source>. <year>1990</year>;<volume>87</volume>:<fpage>66</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr3-1941738112459706">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arroll</surname><given-names>B</given-names></name>
<name><surname>Goodyear-Smith</surname><given-names>F</given-names></name>
</person-group>. <article-title>Corticosteroid injections for painful shoulder: a meta-analysis</article-title>. <source>Br J Gen Pract</source>. <year>2005</year>;<volume>55</volume>:<fpage>224</fpage>-<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr4-1941738112459706">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arslan</surname><given-names>S</given-names></name>
<name><surname>Celiker</surname><given-names>R</given-names></name>
</person-group>. <article-title>Comparison of the efficacy of local corticosteroid injection and physical therapy for the treatment of adhesive capsulitis</article-title>. <source>Rheumatol Int</source>. <year>2001</year>;<volume>21</volume>:<fpage>20</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr5-1941738112459706">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bain</surname><given-names>LS</given-names></name>
<name><surname>Balch</surname><given-names>HW</given-names></name>
<name><surname>Wetherly</surname><given-names>JM</given-names></name>
<name><surname>Yeadon</surname><given-names>A</given-names></name>
</person-group>. <article-title>Intraarticular triamcinolone hexacetonide: double-blind comparison with methylprednisolone</article-title>. <source>Br J Clin Pract</source>. <year>1972</year>;<volume>26</volume>:<fpage>559</fpage>-<lpage>561</lpage>.</citation>
</ref>
<ref id="bibr6-1941738112459706">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellamy</surname><given-names>N</given-names></name>
<name><surname>Campbell</surname><given-names>J</given-names></name>
<name><surname>Robinson</surname><given-names>V</given-names></name>
<name><surname>Gee</surname><given-names>T</given-names></name>
<name><surname>Bourne</surname><given-names>R</given-names></name>
<name><surname>Wells</surname><given-names>G</given-names></name>
</person-group>. <article-title>Intraarticular corticosteroid for treatment of osteoarthritis of the knee</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2006</year>;<fpage>CD005328</fpage>.</citation>
</ref>
<ref id="bibr7-1941738112459706">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blaine</surname><given-names>T</given-names></name>
<name><surname>Moskowitz</surname><given-names>R</given-names></name>
<name><surname>Udell</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study</article-title>. <source>J Bone Joint Surg Am</source>. <year>2008</year>;<volume>90</volume>:<fpage>970</fpage>-<lpage>979</lpage>.</citation>
</ref>
<ref id="bibr8-1941738112459706">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>V</given-names></name>
<name><surname>Barr</surname><given-names>S</given-names></name>
<name><surname>Cerisola</surname><given-names>FL</given-names></name>
</person-group>. <article-title>The effectiveness of corticosteroid injections compared with physiotherapeutic interventions for adhesive capsulitis: a systematic review</article-title>. <source>Physiotherapy</source>. <year>2010</year>;<volume>96</volume>:<fpage>95</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr9-1941738112459706">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brockmeier</surname><given-names>SF</given-names></name>
<name><surname>Shaffer</surname><given-names>BS</given-names></name>
</person-group>. <article-title>Viscosupplementation therapy for osteoarthritis</article-title>. <source>Sports Med Arthrosc</source>. <year>2006</year>;<volume>14</volume>:<fpage>155</fpage>-<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr10-1941738112459706">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caldwell</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Intra-articular corticosteroids: guide to selection and indications for use</article-title>. <source>Drugs</source>. <year>1996</year>;<volume>52</volume>:<fpage>507</fpage>-<lpage>514</lpage>.</citation>
</ref>
<ref id="bibr11-1941738112459706">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calis</surname><given-names>MDH</given-names></name>
<name><surname>Ulker</surname><given-names>S</given-names></name>
<name><surname>Kirnap</surname><given-names>M</given-names></name>
<name><surname>Duygulu</surname><given-names>F</given-names></name>
<name><surname>Calis</surname><given-names>HT</given-names></name>
</person-group>. <article-title>Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis?</article-title> <source>Rheumatol Int</source>. <year>2006</year>;<volume>26</volume>:<fpage>536</fpage>-<lpage>540</lpage>.</citation>
</ref>
<ref id="bibr12-1941738112459706">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carrabba</surname><given-names>M</given-names></name>
<name><surname>Paresce</surname><given-names>E</given-names></name>
<name><surname>Angelini</surname><given-names>M</given-names></name>
<name><surname>Galanti</surname><given-names>A</given-names></name>
<name><surname>Marini</surname><given-names>MG</given-names></name>
<name><surname>Cigarini</surname><given-names>P</given-names></name>
</person-group>. <article-title>A comparison of the local tolerability, safety and efficacy of meloxicam and piroxicam suppositories in patients with osteoarthritis: a single-blind, randomized, multicentre study</article-title>. <source>Curr Med Res Opin</source>. <year>1995</year>;<volume>13</volume>:<fpage>343</fpage>-<lpage>355</lpage>.</citation>
</ref>
<ref id="bibr13-1941738112459706">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chakravarty</surname><given-names>K</given-names></name>
<name><surname>Pharoah</surname><given-names>PD</given-names></name>
<name><surname>Scott</surname><given-names>DG</given-names></name>
</person-group>. <article-title>A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis</article-title>. <source>Br J Rheumatol</source>. <year>1994</year>;<volume>33</volume>:<fpage>464</fpage>-<lpage>468</lpage>.</citation>
</ref>
<ref id="bibr14-1941738112459706">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charalambous</surname><given-names>CP</given-names></name>
<name><surname>Tryfonidis</surname><given-names>M</given-names></name>
<name><surname>Sadiq</surname><given-names>S</given-names></name>
<name><surname>Hirst</surname><given-names>P</given-names></name>
<name><surname>Paul</surname><given-names>A</given-names></name>
</person-group>. <article-title>Septic arthritis following intra-articular steroid injection of the knee: a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee</article-title>. <source>Clin Rheumatol</source>. <year>2003</year>;<volume>22</volume>:<fpage>386</fpage>-<lpage>390</lpage>.</citation>
</ref>
<ref id="bibr15-1941738112459706">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chard</surname><given-names>MD</given-names></name>
<name><surname>Hazleman</surname><given-names>R</given-names></name>
<name><surname>Hazleman</surname><given-names>BL</given-names></name>
<name><surname>King</surname><given-names>RH</given-names></name>
<name><surname>Reiss</surname><given-names>BB</given-names></name>
</person-group>. <article-title>Shoulder disorders in the elderly: a community survey</article-title>. <source>Arthritis Rheum</source>. <year>1991</year>;<volume>34</volume>:<fpage>766</fpage>-<lpage>769</lpage>.</citation>
</ref>
<ref id="bibr16-1941738112459706">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cole</surname><given-names>BJ</given-names></name>
<name><surname>Schumacher</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Injectable corticosteroids in modern practice</article-title>. <source>J Am Acad Orthop Surg</source>. <year>2005</year>;<volume>13</volume>:<fpage>37</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr17-1941738112459706">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Cush</surname><given-names>JKA</given-names></name>
</person-group>. <article-title>Synovial fluid analysis, arthrocentesis, and joint injection techniques</article-title>. In: <person-group person-group-type="editor">
<name><surname>Cush</surname><given-names>JKA</given-names></name>
</person-group>., ed. <source>Rheumatology: Diagnosis and Therapeutics</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>; <volume>2000</volume>:<fpage>61</fpage>-<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr18-1941738112459706">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Jong</surname><given-names>BA</given-names></name>
<name><surname>Dahmen</surname><given-names>R</given-names></name>
<name><surname>Hogeweg</surname><given-names>JA</given-names></name>
<name><surname>Marti</surname><given-names>RK</given-names></name>
</person-group>. <article-title>Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: a comparative study of two dose regimens</article-title>. <source>Clin Rehabil</source>. <year>1998</year>;<volume>12</volume>:<fpage>211</fpage>-<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr19-1941738112459706">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaffney</surname><given-names>K</given-names></name>
<name><surname>Ledingham</surname><given-names>J</given-names></name>
<name><surname>Perry</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response</article-title>. <source>Ann Rheum Dis</source>. <year>1995</year>;<volume>54</volume>:<fpage>379</fpage>-<lpage>381</lpage>.</citation>
</ref>
<ref id="bibr20-1941738112459706">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Genovese</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Joint and soft-tissue injection: a useful adjuvant to systemic and local treatment</article-title>. <source>Postgrad Med</source>. <year>1998</year>;<volume>103</volume>:<fpage>125</fpage>-<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr21-1941738112459706">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gigante</surname><given-names>A</given-names></name>
<name><surname>Callegari</surname><given-names>L</given-names></name>
</person-group>. <article-title>The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis</article-title>. <source>Rheumatol Int</source>. <year>2011</year>;<volume>31</volume>:<fpage>427</fpage>-<lpage>444</lpage>.</citation>
</ref>
<ref id="bibr22-1941738112459706">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goldberg</surname><given-names>VM</given-names></name>
<name><surname>Coutts</surname><given-names>RD</given-names></name>
</person-group>. <article-title>Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment</article-title>. <source>Clin Orthop Relat Res</source>. <year>2004</year>:<volume>419</volume>:<fpage>130</fpage>-<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr23-1941738112459706">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>RG</given-names></name>
<name><surname>Gottlieb</surname><given-names>NL</given-names></name>
</person-group>. <article-title>Intra-articular corticosteroids: an updated assessment</article-title>. <source>Clin Orthop Relat Res</source>. <year>1983</year>:<volume>177</volume>:<fpage>235</fpage>-<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr24-1941738112459706">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Griesser</surname><given-names>MJ</given-names></name>
<name><surname>Harris</surname><given-names>JD</given-names></name>
<name><surname>Campbell</surname><given-names>JE</given-names></name>
<name><surname>Jones</surname><given-names>GL</given-names></name>
</person-group>. <article-title>Adhesive capsulitis of the shoulder: a systematic review of the effectiveness of intra-articular corticosteroid injections</article-title>. <source>J Bone Joint Surg Am</source>. <year>2011</year>;<volume>93</volume>:<fpage>1727</fpage>-<lpage>1733</lpage>.</citation>
</ref>
<ref id="bibr25-1941738112459706">
<label>25.</label>
<citation citation-type="journal">
<collab>Guidelines ACoRSoRA: Guidelines for the management of rheumatoid arthritis: 2002 update</collab>. <source>Arthritis Rheum</source>. <year>2002</year>;<volume>46</volume>:<fpage>328</fpage>-<lpage>346</lpage>.</citation>
</ref>
<ref id="bibr26-1941738112459706">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hegedus</surname><given-names>EJ</given-names></name>
<name><surname>Zavala</surname><given-names>J</given-names></name>
<name><surname>Kissenberth</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Positive outcomes with intra-articular glenohumeral injections are independent of accuracy</article-title>. <source>J Shoulder Elbow Surg</source>. <year>2010</year>;<volume>19</volume>:<fpage>795</fpage>-<lpage>801</lpage>.</citation>
</ref>
<ref id="bibr27-1941738112459706">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Itokazu</surname><given-names>M</given-names></name>
<name><surname>Matsunaga</surname><given-names>T</given-names></name>
</person-group>. <article-title>Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder</article-title>. <source>Clinical Ther</source>. <year>1995</year>;<volume>17</volume>:<fpage>946</fpage>-<lpage>955</lpage>.</citation>
</ref>
<ref id="bibr28-1941738112459706">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iwata</surname><given-names>H</given-names></name>
</person-group>. <article-title>Pharmacologic and clinical aspects of intraarticular injection of hyaluronate</article-title>. <source>Clin Orthop Relat Res</source>. <year>1993</year>;<volume>289</volume>:<fpage>285</fpage>-<lpage>291</lpage>.</citation>
</ref>
<ref id="bibr29-1941738112459706">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Izquierdo</surname><given-names>R</given-names></name>
<name><surname>Voloshin</surname><given-names>I</given-names></name>
<name><surname>Edwards</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Treatment of glenohumeral osteoarthritis</article-title>. <source>J Am Acad Orthop Surg</source>. <year>2010</year>;<volume>18</volume>:<fpage>375</fpage>-<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr30-1941738112459706">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jones</surname><given-names>A</given-names></name>
<name><surname>Doherty</surname><given-names>M</given-names></name>
</person-group>. <article-title>Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response</article-title>. <source>Ann Rheum Dis</source>. <year>1996</year>;<volume>55</volume>:<fpage>829</fpage>-<lpage>832</lpage>.</citation>
</ref>
<ref id="bibr31-1941738112459706">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kemper</surname><given-names>F</given-names></name>
<name><surname>Gebhardt</surname><given-names>U</given-names></name>
<name><surname>Meng</surname><given-names>T</given-names></name>
<name><surname>Murray</surname><given-names>C</given-names></name>
</person-group>. <article-title>Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice</article-title>. <source>Curr Med Res Opin</source>. <year>2005</year>;<volume>21</volume>:<fpage>1261</fpage>-<lpage>1269</lpage>.</citation>
</ref>
<ref id="bibr32-1941738112459706">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>N</given-names></name>
<name><surname>Newman</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Complications of intra- and peri-articular steroid injections</article-title>. <source>Br J Gen Pract</source>. <year>1999</year>;<volume>49</volume>:<fpage>465</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr33-1941738112459706">
<label>33.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lanyon</surname><given-names>PDM</given-names></name>
</person-group>. <article-title>Intra-articular therapy</article-title>. In: <person-group person-group-type="editor">
<name><surname>Firestein</surname><given-names>GSPG</given-names></name>
<name><surname>Wollheim</surname><given-names>FA</given-names></name>
</person-group>., eds. <source>Rheumatoid Arthritis: Frontiers in Pathogenesis and Treatment</source>. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2000</year>:<fpage>361</fpage>-<lpage>369</lpage>.</citation>
</ref>
<ref id="bibr34-1941738112459706">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lazarevic</surname><given-names>MB</given-names></name>
<name><surname>Skosey</surname><given-names>JL</given-names></name>
<name><surname>Djordjevic-Denic</surname><given-names>G</given-names></name>
<name><surname>Swedler</surname><given-names>WI</given-names></name>
<name><surname>Zgradic</surname><given-names>I</given-names></name>
<name><surname>Myones</surname><given-names>BL</given-names></name>
</person-group>. <article-title>Reduction of cortisol levels after single intra-articular and intramuscular steroid injection</article-title>. <source>Am J Med</source>. <year>1995</year>;<volume>99</volume>:<fpage>370</fpage>-<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr35-1941738112459706">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>M</given-names></name>
<name><surname>Haq</surname><given-names>AM</given-names></name>
<name><surname>Wright</surname><given-names>V</given-names></name>
<name><surname>Longton</surname><given-names>EB</given-names></name>
</person-group>. <article-title>Periarthritis of the shoulder: a controlled trial of physiotherapy</article-title>. <source>Physiotherapy</source>. <year>1973</year>;<volume>59</volume>:<fpage>312</fpage>-<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr36-1941738112459706">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leopold</surname><given-names>SS</given-names></name>
<name><surname>Warme</surname><given-names>WJ</given-names></name>
<name><surname>Pettis</surname><given-names>PD</given-names></name>
<name><surname>Shott</surname><given-names>S</given-names></name>
</person-group>. <article-title>Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment</article-title>. <source>J Bone Joint Surg Am</source>. <year>2002</year>;<volume>84</volume>:<fpage>1619</fpage>-<lpage>1623</lpage>.</citation>
</ref>
<ref id="bibr37-1941738112459706">
<label>37.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Matsen</surname><given-names>FA</given-names></name>
<name><surname>Rockwood</surname><given-names>CA</given-names></name>
<name><surname>Wirth</surname><given-names>MA</given-names></name>
<name><surname>Lippitt</surname><given-names>SB</given-names></name>
<name><surname>Moby</surname><given-names>P</given-names></name>
</person-group>. <article-title>Glenohumeral arthritis and its management. In: <italic>The Shoulder</italic></article-title>. <edition>3rd ed</edition>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Saunders</publisher-name>; <year>2004</year>:<fpage>879</fpage>-<lpage>1009</lpage>.</citation>
</ref>
<ref id="bibr38-1941738112459706">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merolla</surname><given-names>G</given-names></name>
<name><surname>Sperling</surname><given-names>JW</given-names></name>
<name><surname>Paladini</surname><given-names>P</given-names></name>
<name><surname>Porcellini</surname><given-names>G</given-names></name>
</person-group>. <article-title>Efficacy of Hylan G-F 20 versus 6-methylprednisolone acetate in painful shoulder osteoarthritis: a retrospective controlled trial</article-title>. <source>Musculoskelet Surg</source>. <year>2011</year>;<volume>95</volume>:<fpage>215</fpage>-<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr39-1941738112459706">
<label>39.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Moore</surname><given-names>G</given-names></name>
</person-group>. <article-title>Arthrocentesis technique and intraarticular therapy</article-title>. In: <person-group person-group-type="editor">
<name><surname>Koopman</surname><given-names>WJ</given-names></name>
</person-group>., ed. <source>Arthritis and Allied Conditions: A Textbook of Rheumatology</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>; <year>2001</year>:<fpage>848</fpage>-<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr40-1941738112459706">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moreland</surname><given-names>LW</given-names></name>
</person-group>. <article-title>Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action</article-title>. <source>Arthritis Res Ther</source>. <year>2003</year>;<volume>5</volume>:<fpage>54</fpage>-<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr41-1941738112459706">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neer</surname><given-names>CSSC</given-names></name>
<name><surname>Dalsey</surname><given-names>RM</given-names></name>
</person-group>. <article-title>On the value of the coracohumeral ligament release</article-title>. <source>Orthopedic Trans</source>. <year>1989</year>;<volume>13</volume>:<fpage>235</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr42-1941738112459706">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nesbitt</surname><given-names>LT</given-names></name>
</person-group>. <article-title>Minimizing complications from systemic glucocorticosteroid use</article-title>. <source>Dermatol Clin</source>. <year>1995</year>;<volume>13</volume>(<issue>4</issue>):<fpage>925</fpage>-<lpage>939</lpage>.</citation>
</ref>
<ref id="bibr43-1941738112459706">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Noel</surname><given-names>E</given-names></name>
<name><surname>Hardy</surname><given-names>P</given-names></name>
<name><surname>Hagena</surname><given-names>FW</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff: open-label prospective multicenter study</article-title>. <source>Joint Bone Spine</source>. <year>2009</year>;<volume>76</volume>:<fpage>670</fpage>-<lpage>673</lpage>.</citation>
</ref>
<ref id="bibr44-1941738112459706">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>IMT</given-names></name>
<name><surname>Weldon</surname><given-names>EJ</given-names></name>
<name><surname>Titelman</surname><given-names>RM</given-names></name>
<name><surname>Smith</surname><given-names>KL</given-names></name>
</person-group>. <article-title>Glenohumeral arthritis and its management</article-title>. <source>Phys Med Rehabil Clin N Am</source>. <year>2004</year>;<volume>15</volume>:<fpage>447</fpage>-<lpage>474</lpage>.</citation>
</ref>
<ref id="bibr45-1941738112459706">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pasquali Ronchetti</surname><given-names>I</given-names></name>
<name><surname>Guerra</surname><given-names>D</given-names></name>
<name><surname>Taparelli</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis</article-title>. <source>Rheumatology (Oxford)</source>. <year>2001</year>;<volume>40</volume>:<fpage>158</fpage>-<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr46-1941738112459706">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pyne</surname><given-names>D</given-names></name>
<name><surname>Ioannou</surname><given-names>Y</given-names></name>
<name><surname>Mootoo</surname><given-names>R</given-names></name>
<name><surname>Bhanji</surname><given-names>A</given-names></name>
</person-group>. <article-title>Intra-articular steroids in knee osteoarthritis: a comparative study of triamcinolone hexacetonide and methylprednisolone acetate</article-title>. <source>Clin Rheumatol</source>. <year>2004</year>;<volume>23</volume>:<fpage>116</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr47-1941738112459706">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raynauld</surname><given-names>JP</given-names></name>
<name><surname>Buckland-Wright</surname><given-names>C</given-names></name>
<name><surname>Ward</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Arthritis Rheum</source>. <year>2003</year>;<volume>48</volume>:<fpage>370</fpage>-<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr48-1941738112459706">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rizk</surname><given-names>TE</given-names></name>
<name><surname>Pinals</surname><given-names>RS</given-names></name>
<name><surname>Talaiver</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Corticosteroid injections in adhesive capsulitis: investigation of their value and site</article-title>. <source>Arch Phys Med Rehabil</source>. <year>1991</year>;<volume>72</volume>:<fpage>20</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr49-1941738112459706">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rovetta</surname><given-names>G</given-names></name>
<name><surname>Monteforte</surname><given-names>P</given-names></name>
</person-group>. <article-title>Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder</article-title>. <source>Int J Tissue React</source>. <year>1998</year>;<volume>20</volume>:<fpage>125</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr50-1941738112459706">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Silverstein</surname><given-names>E</given-names></name>
<name><surname>Leger</surname><given-names>R</given-names></name>
<name><surname>Shea</surname><given-names>KP</given-names></name>
</person-group>. <article-title>The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study</article-title>. <source>Am J Sports Med</source>. <year>2007</year>;<volume>35</volume>:<fpage>979</fpage>-<lpage>985</lpage>.</citation>
</ref>
<ref id="bibr51-1941738112459706">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stitik</surname><given-names>TP</given-names></name>
<name><surname>Foye</surname><given-names>PM</given-names></name>
<name><surname>Fossati</surname><given-names>J</given-names></name>
</person-group>. <article-title>Shoulder injections for osteoarthritis and other disorders</article-title>. <source>Phys Med Rehabil Clin N Am</source>. <year>2004</year>;<volume>15</volume>:<fpage>407</fpage>-<lpage>446</lpage>.</citation>
</ref>
<ref id="bibr52-1941738112459706">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strauss</surname><given-names>EJ</given-names></name>
<name><surname>Hart</surname><given-names>JA</given-names></name>
<name><surname>Miller</surname><given-names>MD</given-names></name>
<name><surname>Altman</surname><given-names>RD</given-names></name>
<name><surname>Rosen</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions</article-title>. <source>Am J Sports Med</source>. <year>2009</year>;<volume>37</volume>:<fpage>1636</fpage>-<lpage>1644</lpage>.</citation>
</ref>
<ref id="bibr53-1941738112459706">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tamai</surname><given-names>K</given-names></name>
<name><surname>Mashitori</surname><given-names>H</given-names></name>
<name><surname>Ohno</surname><given-names>W</given-names></name>
<name><surname>Hamada</surname><given-names>J</given-names></name>
<name><surname>Sakai</surname><given-names>H</given-names></name>
<name><surname>Saotome</surname><given-names>K</given-names></name>
</person-group>. <article-title>Synovial response to intraarticular injections of hyaluronate in frozen shoulder: a quantitative assessment with dynamic magnetic resonance imaging</article-title>. <source>J Orthop Sci</source>. <year>2004</year>;<volume>9</volume>(<issue>3</issue>):<fpage>230</fpage>-<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr54-1941738112459706">
<label>54.</label>
<citation citation-type="web">
<article-title>The treatment of glenohumeral joint arthritis: guideline and evidence report</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.aaos.org/research/guidelines/gloguideline.pdf">http://www.aaos.org/research/guidelines/gloguideline.pdf</ext-link>. Published 2008</comment>. <access-date>Accessed May 5, 2012</access-date>.</citation>
</ref>
<ref id="bibr55-1941738112459706">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tobola</surname><given-names>A</given-names></name>
<name><surname>Cook</surname><given-names>C</given-names></name>
<name><surname>Cassas</surname><given-names>KJ</given-names></name>
<etal/>
</person-group>. <article-title>Accuracy of glenohumeral joint injections: comparing approach and experience of provider</article-title>. <source>J Shoulder Elbow Surg</source>. <year>2011</year>;<volume>20</volume>(<issue>7</issue>):<fpage>1147</fpage>-<lpage>1154</lpage>.</citation>
</ref>
<ref id="bibr56-1941738112459706">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tonino</surname><given-names>PM</given-names></name>
<name><surname>Gerber</surname><given-names>C</given-names></name>
<name><surname>Itoi</surname><given-names>E</given-names></name>
<name><surname>Porcellini</surname><given-names>G</given-names></name>
<name><surname>Sonnabend</surname><given-names>D</given-names></name>
<name><surname>Walch</surname><given-names>G</given-names></name>
</person-group>. <article-title>Complex shoulder disorders: evaluation and treatment</article-title>. <source>J Am Acad Orthop Surg</source>. <year>2009</year>;<volume>17</volume>:<fpage>125</fpage>-<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr57-1941738112459706">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Windt</surname><given-names>DA</given-names></name>
<name><surname>Koes</surname><given-names>BW</given-names></name>
<name><surname>Deville</surname><given-names>W</given-names></name>
<name><surname>Boeke</surname><given-names>AJ</given-names></name>
<name><surname>de Jong</surname><given-names>BA</given-names></name>
<name><surname>Bouter</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial</article-title>. <source>BMJ</source>. <year>1998</year>;<volume>317</volume>:<fpage>1292</fpage>-<lpage>1296</lpage>.</citation>
</ref>
<ref id="bibr58-1941738112459706">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waddell</surname><given-names>DD</given-names></name>
<name><surname>Bricker</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review</article-title>. <source>J Surg Orthop Adv</source>. <year>2006</year>;<volume>15</volume>(<issue>1</issue>):<fpage>53</fpage>-<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr59-1941738112459706">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watterson</surname><given-names>JR</given-names></name>
<name><surname>Esdaile</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee</article-title>. <source>J Am Acad Orthop Surg</source>. <year>2000</year>;<volume>8</volume>:<fpage>277</fpage>-<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr60-1941738112459706">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Webber</surname><given-names>TA</given-names></name>
<name><surname>Webber</surname><given-names>AE</given-names></name>
<name><surname>Matzkin</surname><given-names>E</given-names></name>
</person-group>. <article-title>Rate of adverse reactions to more than 1 series of viscosupplementation</article-title>. <source>Orthopedics</source>. <year>2012</year>;<volume>35</volume>:<fpage>e514</fpage>-<lpage>e519</lpage>.</citation>
</ref>
<ref id="bibr61-1941738112459706">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>White</surname><given-names>A</given-names></name>
<name><surname>Tuite</surname><given-names>JD</given-names></name>
</person-group>. <article-title>The accuracy and efficacy of shoulder injections in restrictive capsulitis</article-title>. <source>J Orthop Rheum</source>. <year>1996</year>;<volume>9</volume>:<fpage>37</fpage>-<lpage>40</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>